Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Cantor Fitzgerald
Julphar
Fuji
Citi
Express Scripts
Colorcon
Baxter
Teva
Cipla

Generated: October 17, 2017

DrugPatentWatch Database Preview

Maprotiline hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for maprotiline hydrochloride and what is the scope of maprotiline hydrochloride freedom to operate?

Maprotiline hydrochloride
is the generic ingredient in two branded drugs marketed by Am Therap, Novartis, Watson Labs, Watson Labs Teva, and Mylan, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for maprotiline hydrochloride. One supplier is listed for this compound.

Summary for Generic Name: maprotiline hydrochloride

US Patents:0
Tradenames:2
Applicants:5
NDAs:11
Drug Master File Entries: see list3
Suppliers / Packagers: see list1
Bulk Api Vendors: see list47
Clinical Trials: see list2,284
Patent Applications: see list984
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:maprotiline hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan
MAPROTILINE HYDROCHLORIDE
maprotiline hydrochloride
TABLET;ORAL072285-002Oct 3, 1988RXNoNo► Subscribe► Subscribe► Subscribe
Am Therap
MAPROTILINE HYDROCHLORIDE
maprotiline hydrochloride
TABLET;ORAL072131-001Jan 14, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Am Therap
MAPROTILINE HYDROCHLORIDE
maprotiline hydrochloride
TABLET;ORAL072130-001Jan 14, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
MAPROTILINE HYDROCHLORIDE
maprotiline hydrochloride
TABLET;ORAL071943-001Dec 30, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis
LUDIOMIL
maprotiline hydrochloride
TABLET;ORAL017543-003Sep 30, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
MAPROTILINE HYDROCHLORIDE
maprotiline hydrochloride
TABLET;ORAL071944-001Dec 30, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
MAPROTILINE HYDROCHLORIDE
maprotiline hydrochloride
TABLET;ORAL072285-001Oct 3, 1988RXNoYes► Subscribe► Subscribe► Subscribe
Am Therap
MAPROTILINE HYDROCHLORIDE
maprotiline hydrochloride
TABLET;ORAL072129-001Jan 14, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
MAPROTILINE HYDROCHLORIDE
maprotiline hydrochloride
TABLET;ORAL072162-001Jun 1, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
MAPROTILINE HYDROCHLORIDE
maprotiline hydrochloride
TABLET;ORAL072164-001Jun 1, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Chinese Patent Office
Harvard Business School
McKesson
Chubb
US Department of Justice
Baxter
Cerilliant
Dow
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot